Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
35.7M
-
Shares change
-
+2.16M
-
Total reported value, excl. options
-
$715M
-
Value change
-
+$44.6M
-
Put/Call ratio
-
2.12
-
Number of buys
-
78
-
Number of sells
-
-45
-
Price
-
$20.01
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2017
165 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2017.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.7M shares
of 79.5M outstanding shares and own 44.95% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (3.95M shares), RTW INVESTMENTS, LP (3.5M shares), BlackRock Inc. (3.14M shares), VANGUARD GROUP INC (2.94M shares), D. E. Shaw & Co., Inc. (2.36M shares), STATE STREET CORP (1.76M shares), Boxer Capital, LLC (1.25M shares), SCOPIA CAPITAL MANAGEMENT LP (1.19M shares), FMR LLC (1.16M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.15M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.